Permanens Capital L.P. Has $1.31 Million Position in UnitedHealth Group Incorporated $UNH

Key Points

• Permanens Capital L.P. increased its position in UnitedHealth Group by 68.0% during the first quarter, acquiring an additional 1,009 shares to hold a total of 2,493 shares valued at approximately $1.3 million.
• UnitedHealth Group's CEO, Patrick Hugh Conway, sold 589 shares recently, reducing his ownership by 5.36%, with a total stock value of approximately $3.17 million.
• Analysts have mixed ratings on UnitedHealth Group, with a consensus price target of $354.86 and classifications ranging from "buy" to "strong sell" across various firms.

Permanens Capital L.P. lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 68.0% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,493 shares of the healthcare conglomerate's stock after acquiring an additional 1,009 shares during the period. UnitedHealth Group makes up approximately 0.2% of Permanens Capital L.P.'s investment portfolio, making the stock its 28th largest position. Permanens Capital L.P.'s holdings in UnitedHealth Group were worth $1,306,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Brighton Jones LLC grew its stake in UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after buying an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC grew its stake in UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after buying an additional 2,324 shares in the last quarter. Algert Global LLC boosted its stake in shares of UnitedHealth Group by 5.3% in the 4th quarter. Algert Global LLC now owns 3,175 shares of the healthcare conglomerate's stock valued at $1,606,000 after purchasing an additional 160 shares in the last quarter. CoreCap Advisors LLC boosted its stake in shares of UnitedHealth Group by 127.5% in the 4th quarter. CoreCap Advisors LLC now owns 3,553 shares of the healthcare conglomerate's stock valued at $1,797,000 after purchasing an additional 1,991 shares in the last quarter. Finally, Fiduciary Trust Co boosted its stake in shares of UnitedHealth Group by 1.1% in the 4th quarter. Fiduciary Trust Co now owns 69,828 shares of the healthcare conglomerate's stock valued at $35,323,000 after purchasing an additional 738 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer owned 10,398 shares of the company's stock, valued at $3,171,390. This trade represents a 5.36% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. 0.28% of the stock is currently owned by company insiders.

UnitedHealth Group Trading Up 1.5%

UnitedHealth Group stock traded up $4.72 during mid-day trading on Friday, hitting $315.10. 14,093,579 shares of the stock were exchanged, compared to its average volume of 17,228,082. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The firm's fifty day simple moving average is $288.78 and its two-hundred day simple moving average is $372.56. The stock has a market capitalization of $285.38 billion, a price-to-earnings ratio of 13.65, a PEG ratio of 2.04 and a beta of 0.44.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business's quarterly revenue was up 12.9% compared to the same quarter last year. During the same period last year, the business earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be given a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.8%. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.

Analysts Set New Price Targets

UNH has been the topic of a number of research analyst reports. Oppenheimer reduced their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 30th. UBS Group reiterated a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a report on Wednesday, May 14th. HSBC reiterated a "reduce" rating and issued a $270.00 price objective (down previously from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Finally, Baird R W lowered shares of UnitedHealth Group from a "hold" rating to a "strong sell" rating in a report on Thursday, July 31st. Sixteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $354.86.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.